You are here

  • Home
  • Archive
  • Volume 68, Issue 3
  • MRI bone oedema is the strongest predictor of subsequent radiographic progression in early rheumatoid arthritis. Results from a 2-year randomised controlled trial (CIMESTRA)

Article info

Article menu
Download PDFPDF
Clinical and epidemiological research
MRI bone oedema is the strongest predictor of subsequent radiographic progression in early rheumatoid arthritis. Results from a 2-year randomised controlled trial (CIMESTRA)

Authors

  1. Dr K Hørslev-Petersen, Rheumatism Hospital, University of Southern Denmark, Toldbodgade 3, DK-6300 Gråsten, Denmark; khorslevpetersen{at}gigtforeningen.dk
View Full Text

Citation

Hetland ML, Ejbjerg B, Hørslev-Petersen K, et al
MRI bone oedema is the strongest predictor of subsequent radiographic progression in early rheumatoid arthritis. Results from a 2-year randomised controlled trial (CIMESTRA)
Annals of the Rheumatic Diseases 2009;68:384-390.

Publication history

  • Accepted March 24, 2008
  • First published April 3, 2008.
Online issue publication 
February 12, 2009

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

2009 BMJ Publishing Group and European League Against Rheumatism